Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Evoke Pharma Inc. (EVOK)

  • SEC News
  • Dec. 17, 2025, 21:04 UTC
  • 1
  • 0 comments

New Form POS AM - Evoke Pharma Inc Filed: 2025-12-17 AccNo: 0001193125-25-322685 Size: 25 KB

Comment Full text

Evoke Pharma Inc. (EVOK)

  • SEC News
  • Dec. 17, 2025, 21:03 UTC
  • 1
  • 0 comments

New Form POS AM - Evoke Pharma Inc Filed: 2025-12-17 AccNo: 0001193125-25-322667 Size: 25 KB

Comment Full text

Insulet Corporation (PODD)

  • SEC News
  • Dec. 17, 2025, 21:02 UTC
  • 1
  • 1 comments

(99% Neutral) INSULET CORPORATION (PODD) Announces Executive Changes

Comment Full text

Evoke Pharma Inc. (EVOK)

  • SEC News
  • Dec. 17, 2025, 21:02 UTC
  • 1
  • 0 comments

New Form POS AM - Evoke Pharma Inc Filed: 2025-12-17 AccNo: 0001193125-25-322658 Size: 25 KB

Comment Full text

Tandem Diabetes Care Inc (TNDM)

  • SEC News
  • Dec. 17, 2025, 21:02 UTC
  • 1
  • 1 comments

Novara Mark David 🟡 adjusted position in 3.8K shares (1 derivative) of TANDEM DIABETES CARE INC (TNDM) at $22.11 Transaction Date: Dec 15, 2025 | Filing ID: 000229

Comment Full text

Evoke Pharma Inc. (EVOK)

  • SEC News
  • Dec. 17, 2025, 21:01 UTC
  • 1
  • 0 comments

New Form POS AM - Evoke Pharma Inc Filed: 2025-12-17 AccNo: 0001193125-25-322655 Size: 25 KB

Comment Full text

Incyte Corporation (INCY)

  • SEC News
  • Dec. 17, 2025, 21:01 UTC
  • 1
  • 1 comments

📋 MICHAEL MORRISSEY (Officer) plans to sell 4K shares of INCYTE CORPORATION (at $97.26 each, total $420K) Filed: Dec 17, 2025 | ID: 010436

Comment Full text

Tandem Diabetes Care Inc (TNDM)

  • SEC News
  • Dec. 17, 2025, 21:01 UTC
  • 0
  • 1 comments

Carpenter Rick 🟡 adjusted position in 207 shares (1 derivative) of TANDEM DIABETES CARE INC (TNDM) at $22.11 Transaction Date: Dec 15, 2025 | Filing ID: 000228

Comment Full text

Bionomics Limited (BNOX)

  • SEC News
  • Dec. 17, 2025, 21:01 UTC
  • 0
  • 1 comments

(99% Neutral) Neuphoria Therapeutics Inc. (BNOX) Announces Regulatory Update

Comment Full text

Collegium Pharmaceutical Inc (COLL)

  • SEC News
  • Dec. 17, 2025, 21:01 UTC
  • 0
  • 1 comments

📋 RITA BALICE-GORDON (DIRECTOR) plans to sell 4K shares of COLLEGIUM PHARMACEUTICAL, INC (at $47.03 each, total $172K) Filed: Dec 17, 2025 | ID: 122027

Comment Full text
  • Previous
  • 26
  • 27
  • 28
  • 29
  • 30
  • Next

Search

News categories

  • Technical Exchange News(10587)
  • Event(1969)
  • SEC News(184019)
  • FDA Approval(9827)
  • Company Report(721)
  • Business News(122067)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin